Close Menu
  • Home
  • United States
  • World
  • Politics
  • Business
  • Lifestyle
  • Entertainment
  • Health
  • Science
  • Tech
  • Sports
  • More
    • Web Stories
    • Editor’s Picks
    • Press Release

Subscribe to Updates

Get the latest USA news and updates directly to your inbox.

What's On
Anthropic’s new IPO millionaires awkward about spending their cash: ‘Just vests and jeans’

Anthropic’s new IPO millionaires awkward about spending their cash: ‘Just vests and jeans’

November 20, 2026
Trump stands by Howard Lutnick despite commerce secretary dismissing warning about Nvidia Chinese spy affair

Trump stands by Howard Lutnick despite commerce secretary dismissing warning about Nvidia Chinese spy affair

November 20, 2026
Experimental pancreatic cancer drug doubles survival time in trial

Experimental pancreatic cancer drug doubles survival time in trial

November 20, 2026
Facebook X (Twitter) Instagram
Trending
  • Anthropic’s new IPO millionaires awkward about spending their cash: ‘Just vests and jeans’
  • Trump stands by Howard Lutnick despite commerce secretary dismissing warning about Nvidia Chinese spy affair
  • Experimental pancreatic cancer drug doubles survival time in trial
  • Carlos PenaVega Gets Candid About Quitting Porn When He Started Dating Wife Alexa PenaVega
  • Dodgers can’t catch break from Brewers insults: ‘It just kind of felt like a regular-season game’
  • SNAP recipients push back on junk-food ban with lawsuit claiming health benefits for diabetes, autism
  • Exclusive | Families of victims murdered by California death row criminals back Trump’s meeting with loved ones
  • Protesters rally at Hunter College after Jewish student event canceled
  • Privacy
  • Terms
  • Advertise
  • Contact Us
Join Us
USA TimesUSA Times
Newsletter Login
  • Home
  • United States
  • World
  • Politics
  • Business
  • Lifestyle
  • Entertainment
  • Health
  • Science
  • Tech
  • Sports
  • More
    • Web Stories
    • Editor’s Picks
    • Press Release
USA TimesUSA Times
Home » Experimental pancreatic cancer drug doubles survival time in trial
Experimental pancreatic cancer drug doubles survival time in trial
Entertainment

Experimental pancreatic cancer drug doubles survival time in trial

News RoomBy News RoomNovember 20, 20261 ViewsNo Comments

NEWYou can now listen to articles!

Pairing an experimental pill with standard chemotherapy shrank tumors or halted growth in most patients with advanced pancreatic cancer, according to early clinical trial results presented Friday at a major international cancer conference.

The findings, shared at the EORTC-NCI-AACR Symposium in Barcelona, come from a phase ½ trial testing a daily oral medication called daraxonrasib, along with two standard intravenous chemotherapy drugs, gemcitabine and nab-paclitaxel.

The trial focused on 61 patients whose pancreatic cancer had already spread to other organs and who had not yet received treatment for their advanced disease.

PANCREATIC CANCER PATIENT BEN SASSE SEES ‘MASSIVE’ TUMOR REDUCTION WITH EXPERIMENTAL NEW DRUG

Pancreatic cancer is notoriously difficult to treat because more than half of patients are diagnosed after the disease has already spread, research shows.

In major clinical trials for metastatic pancreatic cancer, chemotherapy alone shrinks tumors in about 23% to 42% of patients, but the disease typically begins growing again after five to six months, and most patients survive between 8 and 11 months.

Combining an experimental daily pill called daraxonrasib with standard chemotherapy shrank tumors or stopped cancer growth in 90.2% of patients with untreated, advanced pancreatic cancer. (iStock)

According to National Cancer Institute data, only about 3% of patients with distant-stage disease live five years past diagnosis.

In the new study, which tracked patients for a median follow-up of 18 months, tumors shrank in 60.7% of cases, including 8.2% where they disappeared entirely on scans. Overall, the combination stopped tumor growth in 90.2% of participants.

FDA APPROVES ONCE-DAILY PILL FOR DEADLY CANCER AFTER PATIENTS’ SURVIVAL RATES NEARLY DOUBLE

Patients went a median of 12.8 months before their cancer worsened, almost double the timeframe typically seen with standard chemotherapy, and 76.6% were still alive at the one-year mark, the study found.

“We are now seeing not only substantial tumor shrinkages, including complete responses, but also durable disease control, with median progression-free survival exceeding one year,” study lead Dr. Wungki Park, a gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center in New York, said in a press release.

woman sits at home while receiving chemo

Most side effects, including rash, diarrhea, fatigue and low blood cell counts, were manageable with standard care, and only 5% of patients stopped treatment due to daraxonrasib. (iStock)

More than 90% of pancreatic cancers are driven by a faulty gene called RAS, which allows tumors to keep growing. Daraxonrasib is designed to turn off that growth signal, something scientists long thought was impossible to fix with medication.

Dr. Elena Garralda, chair of the symposium and co-director of the clinical research program at the Vall d’Hebron Institute of Oncology in Spain, who was not involved in the research, said the results show that RAS-targeted drugs can be combined with existing treatments at the start of treatment to potentially achieve longer-lasting benefits.

CLICK HERE FOR MORE HEALTH STORIES

Side effects included rash, diarrhea, fatigue and low blood cell counts linked to chemotherapy, most of which were manageable with standard care.

Only 5% of patients stopped treatment because of side effects tied to daraxonrasib.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Researchers emphasized that the findings carry some limitations.

Because this was an early-phase, single-group study involving 61 people, all participants received the experimental combination. Without a direct comparison group of patients receiving standard chemotherapy alone, doctors cannot yet confirm how much better the new regimen performs or whether it definitively extends overall survival.

medical scan of human pancreas

Researchers are now running a larger, randomized Phase 3 trial to directly compare the new treatment against standard chemotherapy. (iStock)

The findings also apply strictly to metastatic pancreatic cancer, even though RAS mutations drive several other cancers, including certain lung, colorectal and gynecological cancers. Separate studies would be needed to test whether the combination works in those diseases.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The trial was funded by Revolution Medicines, the California-based developer of daraxonrasib.

CLICK HERE TO DOWNLOAD THE APP

To determine whether these early findings translate into a durable survival benefit, researchers have launched a larger, randomized Phase 3 trial, called RASolute-303, which directly compares daraxonrasib — both on its own and combined with chemotherapy — against standard chemotherapy alone.

Khloe Quill is a lifestyle writer with Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health. 

Share. Facebook Twitter LinkedIn Telegram WhatsApp Email

Keep Reading

Carlos PenaVega Gets Candid About Quitting Porn When He Started Dating Wife Alexa PenaVega

Carlos PenaVega Gets Candid About Quitting Porn When He Started Dating Wife Alexa PenaVega

Protesters rally at Hunter College after Jewish student event canceled

Protesters rally at Hunter College after Jewish student event canceled

Woman Claimed Lover Was an Intruder and Shot at Him When Her Boyfriend Unexpectedly Came Home

Woman Claimed Lover Was an Intruder and Shot at Him When Her Boyfriend Unexpectedly Came Home

USDA releases Bigfoot, Sasquatch records from Forest Service files

USDA releases Bigfoot, Sasquatch records from Forest Service files

Tim Allen and Wife Jane Hajduk’s Relationship Timeline: Marriage, Parenthood and More

Tim Allen and Wife Jane Hajduk’s Relationship Timeline: Marriage, Parenthood and More

Shopping With Friends: Celebrate National Espresso Day with Keurig’s new coffee and espresso maker

Shopping With Friends: Celebrate National Espresso Day with Keurig’s new coffee and espresso maker

Brittany Snow Reveals How She Wishes ‘The Hunting Wives’ Would End for Sophie and Margo (Exclusive)

Brittany Snow Reveals How She Wishes ‘The Hunting Wives’ Would End for Sophie and Margo (Exclusive)

Roborock Black Friday sale takes up to 57% off wet dry vacuum mops

Roborock Black Friday sale takes up to 57% off wet dry vacuum mops

‘The Traitors: New Blood’ Stars Victor and Katie Reveal They Went on a Date After Finale

‘The Traitors: New Blood’ Stars Victor and Katie Reveal They Went on a Date After Finale

Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Trump stands by Howard Lutnick despite commerce secretary dismissing warning about Nvidia Chinese spy affair

Trump stands by Howard Lutnick despite commerce secretary dismissing warning about Nvidia Chinese spy affair

November 20, 2026
Experimental pancreatic cancer drug doubles survival time in trial

Experimental pancreatic cancer drug doubles survival time in trial

November 20, 2026
Carlos PenaVega Gets Candid About Quitting Porn When He Started Dating Wife Alexa PenaVega

Carlos PenaVega Gets Candid About Quitting Porn When He Started Dating Wife Alexa PenaVega

November 20, 2026
Dodgers can’t catch break from Brewers insults: ‘It just kind of felt like a regular-season game’

Dodgers can’t catch break from Brewers insults: ‘It just kind of felt like a regular-season game’

November 20, 2026

Subscribe to News

Get the latest USA news and updates directly to your inbox.

Latest News
SNAP recipients push back on junk-food ban with lawsuit claiming health benefits for diabetes, autism

SNAP recipients push back on junk-food ban with lawsuit claiming health benefits for diabetes, autism

November 20, 2026
Exclusive | Families of victims murdered by California death row criminals back Trump’s meeting with loved ones

Exclusive | Families of victims murdered by California death row criminals back Trump’s meeting with loved ones

November 20, 2026
Protesters rally at Hunter College after Jewish student event canceled

Protesters rally at Hunter College after Jewish student event canceled

November 20, 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 USA Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.